Blog (5)

Infectious Diseases Vaccines

March 5, 2018 Ayaskant Pany, MD

Laboratory Expertise for Early Bactericidal Activity (EBA) Studies

Authors: Dr. Ayaskant Pany and Sorika Van NiekerkRead somewhere recently: “What is the biggest constraint for tuberculosis (TB) clinical trials? RESOURCES!” This is so true not only in the...

Bioanalytical Laboratories ADME Immunoassay Services

November 28, 2017 Kevin Jones, MBA

Industry Insights from a Veteran

My entire professional career, beginning from graduation from college, has been focused on fee-for-service analytical services supporting the pharmaceutical and drug development industry on a global...

October 30, 2017 Victor Weigman, Ph.D.

Genomic Testing for Insulin Resistance

Authors: Marc Edwards & Victor WeigmanAs we celebrate the efforts of so many researchers, providers, patients, and advocates on World Diabetes Day, we have much to be excited about today. New...

Vaccines

April 7, 2017 Default Author

Vaccines in the Fight against Malaria

The theme for this year’s World Immunization Week, “#VaccinesWork”, rings true for the many diseases from which vaccines are protecting people of all ages across the globe. Yet, there are more...

Central Laboratories End-to-End Services Vaccines

April 7, 2017 Default Author

A CRO lab perspective on Ebola vaccine development

This month, during World Immunization Week (April 24-30, 2017), we recognize immunizations as one of the world’s most important and effective health interventions, responsible for saving countless...

Infectious Diseases Vaccines

March 8, 2017 Ayaskant Pany, MD

What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow?

Despite significant annual variation in research funding and global funding totals that fall far short of the field’s reported needs, the global market in tuberculosis (TB) diagnostics and treatments...

Infectious Diseases Vaccines

March 7, 2017 Ayaskant Pany, MD

A Super Battle Against Superbugs: Developing an Effective Drug-Resistant Tuberculosis Research Strategy

When most people think of emerging threats to public health, tuberculosis (TB) is unlikely to rise to the forefront of their minds. After all, TB has a long history and has been a well-known global...

End-to-End Services

February 24, 2017 Jenny Zhang

Delivering Excellence in China

In 2015 the China Food and Drug Administration (CFDA) ordered companies responsible for 1600+ new drug applications in China to conduct a “self-examination on the authenticity, integrity and...

Genomics

January 24, 2017 Victor Weigman, Ph.D.

Using Gene Signature Methodologies to strengthen Immuno Oncology Trials

The theme for this year’s World Cancer Day highlights the part we can all play in the fight against cancer. “We can. I can.” is a call to action for individuals and groups to contribute what they...

End-to-End Services Biomarkers

January 23, 2017 Patrick Hurban, Ph.D.

The End to End Importance of Selecting the Right Biomarker in Cancer Studies

Researchers, healthcare providers, patients, families and friends join together on World Cancer Day to reaffirm our commitment to a unified fight against a disease that affects billions of people...

Blog

Filter By Topic

Search Blog Articles

Laboratory Expertise for Early Bactericidal Activity (EBA) Studies

Industry Insights from a Veteran

Genomic Testing for Insulin Resistance

Vaccines in the Fight against Malaria

A CRO lab perspective on Ebola vaccine development

What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow?

A Super Battle Against Superbugs: Developing an Effective Drug-Resistant Tuberculosis Research Strategy

Delivering Excellence in China

Using Gene Signature Methodologies to strengthen Immuno Oncology Trials

The End to End Importance of Selecting the Right Biomarker in Cancer Studies